Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  zinostatin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-12 of 12 for your search:
Start Over
Phase II-III Trial of Neocarzinostatin vs m-AMSA or ADR in Advanced Hepatocellular Carcinoma
Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1280
Phase III Chemotherapy with PALA, AMSA, VM-26, and NCS as Single Agents in Small Cell Lung Cancer
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-2579
Phase II Chemotherapy with Neocarzinostatin for Advanced Metastatic Urothelial Bladder Carcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-7757
Phase II Chemotherapy with Neocarzinostatin for Acute Lymphocytic or Acute Nonlymphocytic Leukemia in Children
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and under
Sponsor: NCI
Protocol IDs: POG-7831, MDAR-319
Phase II Hepatic Infusion Therapy with FUDR, MTX/TDR, NZS, ADR, BCNU, DCM for Primary or Metastatic Liver Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: DFCI-76050
Phase II Chemotherapy with Neocarzinostatin for Solid Tumors and Leukemias
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-77002
Phase II Chemotherapy with Neocarzinostatin for Acute Leukemia and for Various Solid Tumors
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: CLB-0704
Phase II Master Protocol and Trials with AMSA and Neocarzinostatin for non-Small Cell Lung Carcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: under 75
Sponsor: NCI
Protocol IDs: EST-1579
Phase II Master Protocol with MeCCNU, MeCCNU/BCG, MeCCNU/HU/DTIC, BCG, ACT-D/HU/DTIC, CLZ, NZS, MGBG, or DBD Therapy for Metastatic Melanoma
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-1675
Phase II Chemotherapy with NZS for Chronic and Acute Leukemias, Lymphoma, and Liver, Renal, and Bladder Carcinomas
Phase: Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7534A
Phase I Chemotherapy with Neocarzinostatin for Solid Tumors and Hematologic Malignancies
Phase: Phase I
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7534
Chemotherapy with VP-16213 plus Neocarzinostatin for Adult Hepatocellular Carcinoma
Phase: No phase specified
Type: Treatment
Status: Closed
Age: 15 to 70
Sponsor:
Protocol IDs: UMCC-7809
Start Over